GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tellgen Corp (SZSE:300642) » Definitions » Price-to-Free-Cash-Flow

Tellgen (SZSE:300642) Price-to-Free-Cash-Flow : 36.56 (As of Jun. 24, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Tellgen Price-to-Free-Cash-Flow?

As of today (2024-06-24), Tellgen's share price is ¥11.26. Tellgen's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.31. Hence, Tellgen's Price-to-Free-Cash-Flow Ratio for today is 36.56.

The historical rank and industry rank for Tellgen's Price-to-Free-Cash-Flow or its related term are showing as below:

SZSE:300642' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 35.6   Med: 110.96   Max: 1013.77
Current: 36.56

During the past 12 years, Tellgen's highest Price-to-Free-Cash-Flow Ratio was 1013.77. The lowest was 35.60. And the median was 110.96.

SZSE:300642's Price-to-Free-Cash-Flow is ranked worse than
55.18% of 328 companies
in the Medical Devices & Instruments industry
Industry Median: 31.425 vs SZSE:300642: 36.56

Tellgen's Free Cash Flow per Share for the three months ended in Mar. 2024 was ¥0.08. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ¥0.31.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Tellgen was 58.80% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 12.90% per year.

During the past 12 years, Tellgen's highest 3-Year average Free Cash Flow per Share Growth Rate was 18.70% per year. The lowest was -21.70% per year. And the median was 9.75% per year.


Tellgen Price-to-Free-Cash-Flow Historical Data

The historical data trend for Tellgen's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tellgen Price-to-Free-Cash-Flow Chart

Tellgen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.72 298.03 - 34.59 114.61

Tellgen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 120.67 42.46 55.94 114.61 45.52

Competitive Comparison of Tellgen's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Tellgen's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tellgen's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tellgen's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Tellgen's Price-to-Free-Cash-Flow falls into.



Tellgen Price-to-Free-Cash-Flow Calculation

Tellgen's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=11.26/0.308
=36.56

Tellgen's Share Price of today is ¥11.26.
Tellgen's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.31.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Tellgen  (SZSE:300642) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Tellgen Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Tellgen's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Tellgen (SZSE:300642) Business Description

Traded in Other Exchanges
N/A
Address
No. 115, Lane 572, Bibo Road, Building 1, Zhangjiang Hi-Tech Park, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Tellgen Corp manufactures and distributes in vitro diagnostic devices for detection of tumor. Its products include tumor marker, human papillomavirus, real time PCR, DNA methylation, autoimmune antibody, infectious disease and others. The company has developed products in the fields of tumor detection, cervical cancer screening, DNA methylation detection, male infertility and prenatal and postnatal care. Its products include tumor marker series products, human papillomavirus series products, Y chromosome microdeletion detection products, real time PCR, autoimmune antibody, and others.
Executives
Zhou Ai Guo Directors, executives
Chen Si Han Securities Affairs Representative

Tellgen (SZSE:300642) Headlines

No Headlines